From thorne@agibusiness.com  Wed May 23 09:30:57 2007
Return-Path: <thorne@agibusiness.com>
Received: from flax24.uwaterloo.ca (flax24.uwaterloo.ca [129.97.186.224])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l4NDUuqD025682
	for <captains@flax9.uwaterloo.ca>; Wed, 23 May 2007 09:30:56 -0400
Received: from Agibusiness.com (208-53-15-73.ttlsystems.com [208.53.15.73])
	by flax24.uwaterloo.ca (8.12.8/8.12.8) with ESMTP id l4NCWQou024035
	for <captains@wheat.uwaterloo.ca>; Wed, 23 May 2007 08:32:26 -0400
To: <captains@flax24.uwaterloo.ca>
Date: Wed, 23 May 2007 09:30:52 -0400
From: "BioStem Annnouncement"<David.Thorne@agibusiness.com>
Message-ID: <38457340103BN@Agibusiness.com>
X-ID: "2279502384573"
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="--60804090903070300040701502384573--"
Subject: BTEM announces 8 facilities under contract

----60804090903070300040701502384573--
Content-Type: text/plain; charset="iso-8859-1"

BTEM announces 8 facilities under contract
http://Agibusiness.com/cgi-bin/clickthru/6200/2279/384573


ATLANTA, GA--(MARKET WIRE)--May 23, 2007 -- BioStem, Inc. (OTC BB:BTEM.OB - News)  - http://Agibusiness.com/cgi-bin/clickthru/6201/2279/384573

announces: Cryobanks International (Cryobanks), which has agreed to be acquired by BioStem, Inc., has implemented an expansion to its global marketing campaign due to the heightened demand for licensing of its world-recognized cord blood technology. In addition to the eight facilities presently under contract, the marketing & sales campaign will now encompass over 11 countries with revenue projections exceeding $25M.
http://Agibusiness.com/cgi-bin/clickthru/6202/2279/384573





--------------------------------------------
Rmove here 
http://Agibusiness.com/cgi-bin/unsub.cgi/2279/384573

----60804090903070300040701502384573--
Content-Type: text/html; charset="iso-8859-1"

<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
<title>BTEM announces 8 facilities under contract</title>
</head>

<body>

<img src="http://Agibusiness.com/cgi-bin/view/608/2279/384573" width="1" height="1" alt="BTEM announces 8 facilities under contract" title="BTEM announces 8 facilities under contract">
<br />
<center>

<a href="http://Agibusiness.com/cgi-bin/clickthru/6195/2279/384573"><font color="#000000">BTEM announces 8 facilities under contract</font></a>
<br />
<br />

<style type="text/css">
<!--
style1 {
font-family: Geneva, Arial, Helvetica, sans-serif;
color: #716EB8;
font-weight: bold;
font-size: 14pt;
}
style2 {
font-family: Geneva, Arial, Helvetica, sans-serif;
font-size: 14px;
color: #143256;
}
style3 {font-family: Geneva, Arial, Helvetica, sans-serif; font-size: 14px; color: #4c4c4c; font-weight: bold; }
a:link {
color: #143256;
}
a:visited {
color: #143256;
}
a:hover {
color: #143256;
}
a:active {
color: #143256;
}
body {
background-color: #D3E7F5;
}
style14 {font-family: Geneva, Arial, Helvetica, sans-serif; font-size: 14px; color: #000000; }
style19 {
color: #213C5A;
font-size: 13pt;
}

-->
</style>


<div align="center">

<table border="0" width="101%" cellpadding="0" style="border-collapse: collapse" height="100%" id="table1">
<tr>
  <td align="center" valign="top"><table width="750" cellspacing="0" cellpadding="0">
              
              <tr>
                <td colspan="3"><a href="http://Agibusiness.com/cgi-bin/clickthru/6196/2279/384573"><img src="http://Agibusiness.com/e/BTEM0523/header.gif" width="765" height="122" border="0"></a></td>
              </tr>
              <tr>
                <td width="20" height="504" valign="top" background="http://Agibusiness.com/e/BTEM0523/left_blue.gif">&nbsp;</td>
                <td width="721" valign="top"><table width="100%" cellpadding="0" cellspacing="0" bgcolor="#ECECEC">

                  
                  <tr>
                    <td height="224" colspan="4"><table width="100%" cellspacing="0" cellpadding="0">
                      <tr>
                        <td height="24" colspan="3" class="style1"><table width="99%" cellspacing="0" cellpadding="0">
                          <tr>
                            <td width="2%" height="29" bgcolor="#ECECEC">&nbsp;</td>
                            <td width="98%" valign="middle" bgcolor="#B4D2EF" class="style1"><p align="center"><span class="style19">BTEM
                                Announces: Cryobanks' International Licensing
                                Campaign <br>
                                Propels Forward as Eight Facilities
                                Are Now Under Contract; Campaign <br>

                                Targets 11 Additional
                                Countries Producing Over $25M in Revenues</span><BR>
                              </p></td>
                          </tr>
                        </table></td>
                        <td bgcolor="#ECECEC">&nbsp;</td>
                      </tr>
                      <tr>
                        <td width="42%" height="211" valign="middle"><div align="center"><img src="http://Agibusiness.com/e/BTEM0523/logo.gif" width="296" height="168"></div></td>

                        <td width="1%" bgcolor="#ECECEC">&nbsp;</td>
                        <td width="55%" valign="middle" class="style2"><p class="style14"><strong>ATLANTA,
                            GA--(MARKET WIRE)--May 23, 2007</strong> -- BioStem, Inc.
                            (OTC BB:<a href="http://Agibusiness.com/cgi-bin/clickthru/6197/2279/384573">BTEM.OB</a> - <a href="http://Agibusiness.com/cgi-bin/clickthru/6198/2279/384573">News</a>)
                            announces: Cryobanks International (Cryobanks), which
                            has agreed to be acquired by BioStem, Inc., has implemented
                            an expansion to its global marketing campaign due
                            to the heightened demand for licensing of its world-recognized
                            cord blood technology. In addition to the eight facilities
                            presently under contract, the marketing &amp; sales
                            campaign will now encompass over 11 countries with
                            revenue projections exceeding $25M.</p>
                        </td>
                        <td width="2%" bgcolor="#ECECEC">&nbsp;</td>

                      </tr>
                    </table></td>
                  </tr>
                  <tr>
                    <td width="1" height="226" colspan="2" bgcolor="#ECECEC">&nbsp;</td>
                    <td width="97%" height="226" valign="top" bgcolor="#ECECEC" ><p class="style14">Cryobanks, which possess one of the world's largest
                        cord blood stem cell inventories, intends to implement
                        its cord blood technology through multiple international
                        licensing agreements through representation by contracted
                        industry experts. Through each licensing agreement, Cryobanks
                        will receive large initial compensation as well as annual
                        royalties.</p>
                      <p class="style14">According to Cryobanks' CEO, Dwight
                          Brunoehler, "The
                        overwhelming demand for the unique service that Cryobanks
                        provides taxes our in-house staff to the limit. Having
                        local representation on the ground in each targeted country
                        will help to identify and prioritize our opportunities."</p>
                      <p class="style14">At the time of writing, Cryobanks has facilities in
                        Athens, Greece and Delhi, India. Of the eight facilities
                        under contract, the Bangkok, Thailand location is expected
                        to open within the next 60 days. Detailed revenue breakdowns
                        as well as progress updates covering the presently operating
                        facilities will be released in the near future.</p></td>

                    <td width="1%" bgcolor="#ECECEC" class="style3">&nbsp;</td>
                  </tr>
                  
                </table></td>
                <td width="24" background="http://Agibusiness.com/e/BTEM0523/right_blue.gif">&nbsp;</td>
              </tr>
              <tr>
                <td colspan="3"><a href="http://Agibusiness.com/cgi-bin/clickthru/6199/2279/384573"><img src="http://Agibusiness.com/e/BTEM0523/footer_blue.gif" width="765" height="78" border="0"></a></td>
              </tr>
            </table>  

    <p><img src="http://Agibusiness.com/e/BTEM0523/disclaim.gif" width="732" height="339"></p></td>

</tr>
  </table>

<br/><br/>
Wish to no longer get mail, <a href="http://Agibusiness.com/cgi-bin/unsub.cgi/2279/384573"/>rmove here<br/>
<img src="http://Agibusiness.com/images/move.jpg" alt="BTEM announces 8 facilities under contract" title="BTEM announces 8 facilities under contract" border="0"/></a>
</center>
</BODY></HTML>


----60804090903070300040701502384573----

